La-Z-Boy Moves On

Recs

0

Getting out of a comfortable chair is never easy, especially when Family Guy reruns are on and there's a large bowl of roasted peanuts sitting on the coffee table. But that's just what Jerry Kiser did last night, resigning as president and COO of La-Z-Boy (NYSE: LZB). Apparently, investors didn't take the news particularly well, as the shares fell approximately 8% in morning trading.

La-Z-Boy stockholders can be forgiven for betraying some uncertainty, even if Kiser's replacement -- Kurt Darrow, formerly president of the company's largest division -- has some 24 years of company experience under his belt. (Kiser, a director of May Nasdaq debutant MBT Financial (Nasdaq: MBTF), also had considerable experience at the company, but two dozen years is nothing to sneeze at.) Even so, high-level executive change, barring the expulsion of a blatantly incompetent or criminal individual, is almost always met with some trepidation.

That for La-Z-Boy there's plenty of reason to believe that all is not lost finds support in the fact that the shares ticked slowly higher today. The company was a solid performer well before Kiser took over, and actually outperformed the S&P 500 Index over the last decade, despite operating in a sector that few would call "sexy".

As highlighted by Matthew Emmert in this summer's Stocks for Dad feature, La-Z-Boy is a well-run company with strong financials and improving efficiencies. Acquisitions completed under Kiser, which may have caused near-term concern among some investors in recent years, appear to be performing well. More generally, historically well-run companies that have clear succession plans in place -- as La-Z-Boy appears to have --can handle change with aplomb.

For ideas on how to track the effectiveness of the folks running the companies in which you place your faith and money, consider revisiting our 2001 feature on how to evaluate management .

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 499116, ~/Articles/ArticleHandler.aspx, 12/1/2009 11:26:52 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
The Public Health-Care Plan's Problem

Related Tickers

12/1/2009 11:10 AM
LZB $9.54 Down -0.01 -0.10%
La-Z-Boy, Inc. CAPS Rating: *
MBTF $1.68 Up +0.01 +0.60%
MBT Financial Corp… CAPS Rating: No stars

Community: Investing Wiki

Term Of The Hour

PDUFA: The Prescription Drug User Fee Act (PDUFA) is a law enacted by Congress that gives powers to the FDA.

Want to learn more or edit this definition?
Click here to read more!